Indeed, AP-1 activity has been shown to be the major TF involved in the remodeling of the chromatin during T-cell activation and sites in AP-1 are highly overlapping with risk loci for immunological diseases, particularly in MS (46). This evidence concerns the gene TF and myeloid sarcoma.